Genoa Ventures — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
BrightSpecbrightspec.cominMay 2025
BrightSpec develops molecular rotational resonance (MRR) spectroscopy instruments and software that identify and quantify gas-phase molecules from complex mixtures without front-end separation.
BiotechDeep TechHardwareWaltham, US
Rick Gordon(CEO)inWalter Colsman(Executive Officer, Director)JAFFRAY WOODRIFF(Director)ROBERT LLOYD(Executive Officer, Director)THOMAS JONES(Director)DAVID MCDANIEL(Executive Officer, Director)
Board seatJenny Rooke· per SEC Form D
Co-investorsArboretum VenturesMedvest Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.